(S)-(+)-N-3-Benzylnirvanol

CAS No. 790676-40-3

(S)-(+)-N-3-Benzylnirvanol( —— )

Catalog No. M36083 CAS No. 790676-40-3

(S)-(+)-N-3-Benzylnirvanol is a cytochrome P450 CYP2C19 inhibitor with a ki value of 82.5μM for CYP2C9 and 0.25μM for CYP2C19, which can be used to study HIV infection.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 359 In Stock
10MG 531 In Stock
25MG 839 In Stock
50MG 1107 In Stock
100MG 1469 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (S)-(+)-N-3-Benzylnirvanol
  • Note
    Research use only, not for human use.
  • Brief Description
    (S)-(+)-N-3-Benzylnirvanol is a cytochrome P450 CYP2C19 inhibitor with a ki value of 82.5μM for CYP2C9 and 0.25μM for CYP2C19, which can be used to study HIV infection.
  • Description
    (S)-(+)-N-3-Benzylnirvanol is a drug used formetabolic regulation. (S)-(+)-N-3-Benzylnirvanol has the activity of inhibitinghuman P450 enzyme. (S)-(+) -n-3-benzylnirvanol can be used to study druginteractions during drug metabolism .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV Protease | P450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    790676-40-3
  • Formula Weight
    294.35
  • Molecular Formula
    C18H18N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (339.73 mM; Ultrasonic )
  • SMILES
    C(C)[C@@]1(C(=O)N(CC2=CC=CC=C2)C(=O)N1)C3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. KimMJ, et al. High-throughput screening of inhibitory potential of nine cytochromeP450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.Rapid Commun Mass Spectrom. 2005;19(18):2651-8.?
molnova catalog
related products
  • Deoxyrhapontin

    Desoxyrhaponticin and rhaponticin could be considered as promising fatty acid synthase(FAS) inhibitors, they could inhibit intracellular FAS activity and downregulate FAS expression in human breast cancer MCF-7 cells.

  • NPD4456

    A coumarin-based HIV-1 viral protein R (Vpr) inhibitor, inhibits Vpr-dependent viral infection of human macrophages.

  • Cyclotriazadisulfona...

    Cyclotriazadisulfonamide hydrochloride is a selective inhibitor of CD4-targeted HIV entry and inhibits the co-translational translocation of human CD4 into the ER lumen in a signal peptide-dependent way.